Phase II, open-label study of erdafitinib in adult and adolescent patients (pts) with advanced solid tumours harboring fibroblast growth factor receptor (FGFR) gene alterations Meeting Abstract
| Authors: | Schuler, M.; Tabernero, J.; Massard, C.; Vasudeva Iyer, G.; Witt, O.; Doi, T.; Qin, S.; Lu-Emerson, C.; Hargrave, D.; Garcia-Corbacho, J.; Little, S.; Xia, Q.; Santiago-Walker, A.; Moy, C. H.; Hammond, C.; Lau, Y. Y.; Sweiti, H.; Pant, S. |
| Abstract Title: | Phase II, open-label study of erdafitinib in adult and adolescent patients (pts) with advanced solid tumours harboring fibroblast growth factor receptor (FGFR) gene alterations |
| Meeting Title: | ESMO Virtual Congress 2020 |
| Journal Title: | Annals of Oncology |
| Volume: | 31 |
| Issue: | Suppl. 4 |
| Meeting Dates: | 2020 Sep 19-21/Oct 16-18 |
| Meeting Location: | Virtual |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2020-09-01 |
| Start Page: | S502 |
| End Page: | S503 |
| Language: | English |
| ACCESSION: | WOS:000573469100601 |
| DOI: | 10.1016/j.annonc.2020.08.717 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 603TiP -- Source: Wos |
